Ataxia telangiectasia mutated and p21CIP1 modulate cell survival of drug-induced senescent tumor cells: implications for chemotherapy
- PMID: 18347191
- DOI: 10.1158/1078-0432.CCR-07-4298
Ataxia telangiectasia mutated and p21CIP1 modulate cell survival of drug-induced senescent tumor cells: implications for chemotherapy
Abstract
Purpose: Premature or stress-induced senescence is a major cellular response to chemotherapy in solid tumors and contributes to successful treatment. However, senescent tumor cells are resistant to apoptosis and may also reenter the cell cycle. We set out to find a means to specifically induce senescent tumor cells to undergo cell death and not to reenter the cell cycle that may have general application in cancer therapy.
Experimental design: We investigated the mechanisms regulating cell survival in drug-induced senescent tumor cells. Using immunofluorescence and flow cytometry-based techniques, we established the status of the ataxia telangiectasia mutated (ATM) signaling pathway in these cells. We assayed the requirement of ATM signaling and p21(CIP1) expression for survival in premature senescent tumor cells using pharmacologic inhibitors and antisense oligonucleotides.
Results: The ATM/ATR (ATM- and Rad3-related) signaling pathway was found to be constitutively active in drug-induced senescent tumor cells. We found that blocking ATM/ATR signaling with pharmacologic inhibitors, including the novel ATM inhibitors KU55933 and CGK733, induced senescent breast, lung, and colon carcinoma cells to undergo cell death. We show that the mechanism of action of this effect is directly via p21(CIP1), which acts downstream of ATM. This is in contrast to the effects of ATM inhibitors on normal, untransformed senescent cells.
Conclusions: Blocking ATM and/or p21(CIP1) following initial treatment with a low dose of senescence-inducing chemotherapy is a potentially less toxic and highly specific treatment for carcinomas.
Similar articles
-
Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response.Cancer Res. 2007 Feb 1;67(3):1046-53. doi: 10.1158/0008-5472.CAN-06-2371. Cancer Res. 2007. PMID: 17283137
-
Proinflammatory cytokine-induced cellular senescence of biliary epithelial cells is mediated via oxidative stress and activation of ATM pathway: a culture study.Free Radic Res. 2008 Jul;42(7):625-32. doi: 10.1080/10715760802244768. Epub 2008 Jun 25. Free Radic Res. 2008. PMID: 18608517
-
Persistence of unrepaired DNA double strand breaks caused by inhibition of ATM does not lead to radio-sensitisation in the absence of NF-κB activation.DNA Repair (Amst). 2011 Feb 7;10(2):235-44. doi: 10.1016/j.dnarep.2010.11.005. Epub 2010 Dec 8. DNA Repair (Amst). 2011. PMID: 21144805
-
The role of ATM in breast cancer development.Breast Cancer Res Treat. 2007 Aug;104(2):121-8. doi: 10.1007/s10549-006-9406-6. Epub 2006 Oct 24. Breast Cancer Res Treat. 2007. PMID: 17061036 Review.
-
[A cell and genotoxic stress: a reaction to double strand breaks of DNA].Cas Lek Cesk. 2005;144 Suppl 3:13-7. Cas Lek Cesk. 2005. PMID: 16335257 Review. Czech.
Cited by
-
The ataxia telangiectasia mutated kinase pathway regulates IL-23 expression by human dendritic cells.J Immunol. 2013 Apr 1;190(7):3246-55. doi: 10.4049/jimmunol.1201484. Epub 2013 Mar 4. J Immunol. 2013. PMID: 23460736 Free PMC article.
-
Cellular Responses to Platinum-Based Anticancer Drugs and UVC: Role of p53 and Implications for Cancer Therapy.Int J Mol Sci. 2020 Aug 11;21(16):5766. doi: 10.3390/ijms21165766. Int J Mol Sci. 2020. PMID: 32796711 Free PMC article. Review.
-
PERK/CHOP contributes to the CGK733-induced vesicular calcium sequestration which is accompanied by non-apoptotic cell death.Oncotarget. 2015 Sep 22;6(28):25252-65. doi: 10.18632/oncotarget.4487. Oncotarget. 2015. PMID: 26259235 Free PMC article.
-
Cisplatin resistance reversal by disulfiram and caffeine.J Pharmacol Pharmacother. 2016 Jul-Sep;7(3):139-41. doi: 10.4103/0976-500X.189676. J Pharmacol Pharmacother. 2016. PMID: 27651711 Free PMC article. No abstract available.
-
Diversity of the Senescence Phenotype of Cancer Cells Treated with Chemotherapeutic Agents.Cells. 2019 Nov 23;8(12):1501. doi: 10.3390/cells8121501. Cells. 2019. PMID: 31771226 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous